Viridian Therapeutics, Inc. (NASDAQ: VRDN), a biotechnology company advancing new treatments for patients suffering from serious diseases underserved by current therapies, announced that senior management will participate in the 5th Annual Evercore ISI HealthCONx Conference on Thursday, December 1, 2022.
https://www.marketscreener.com/quote/stock/VIRIDIAN-THERAPEUTICS-IN-34091127/news/Viridian-Therapeutics-Inc-a-biotechnology-company-advancing-new-treatments-for-patients-suffering-42429454/
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.